Suppr超能文献

与盐酸安非他酮缓释剂型相关的睡眠期尿失禁

Urinary Incontinence during Sleep Associated with Extended Release Form of Bupropion HCI.

作者信息

Izci Filiz, Iris Koc Merve, Bilici Rabia, Yalcin Murat, Bestepe Engin Emrem

机构信息

Department of Psychiatry, School of Medicine, Istanbul Bilim University, Abide-i Hurriyet Caddesi No. 164, Sisli, Istanbul, Turkey.

Department of Psychiatry, Erenkoy Training and Research Hospital for Psychiatric and Neurological Disorders, 19 Mayıs Mah, Bayar Caddesi, Kadikoy, Istanbul, Turkey.

出版信息

Case Rep Psychiatry. 2015;2015:906294. doi: 10.1155/2015/906294. Epub 2015 Nov 3.

Abstract

Bupropion hydrochloride (HCI) is an antidepressant that acts as a norepinephrine and dopamine reuptake inhibitor and has three different dosage forms including immediate release (IR), sustained release (SR), and extended release (ER). Despite its relatively safe side effect profile bupropion may cause several side effects. Here, we aimed to report a case with major depression using extended release form of bupropion hydrochloride who was presented with urinary incontinence during sleep, an uncommon side effect of bupropion.

摘要

盐酸安非他酮是一种抗抑郁药,作为去甲肾上腺素和多巴胺再摄取抑制剂,有三种不同剂型,包括速释(IR)、缓释(SR)和长效释放(ER)。尽管盐酸安非他酮的副作用相对安全,但仍可能引起一些副作用。在此,我们旨在报告一例使用盐酸安非他酮长效释放剂型治疗重度抑郁症的患者,该患者在睡眠中出现尿失禁,这是安非他酮一种不常见的副作用。

相似文献

1
Urinary Incontinence during Sleep Associated with Extended Release Form of Bupropion HCI.
Case Rep Psychiatry. 2015;2015:906294. doi: 10.1155/2015/906294. Epub 2015 Nov 3.
2
Bupropion Hydrochloride Sustained Release and Diurnal Enuresis: A Previously Unreported Adverse Effect.
Clin Neuropharmacol. 2019 Nov/Dec;42(6):211-213. doi: 10.1097/WNF.0000000000000364.
3
Bupropion sustained release: side effect profile.
J Clin Psychiatry. 1998;59 Suppl 4:32-6.
4
A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor.
Prim Care Companion J Clin Psychiatry. 2004;6(4):159-166. doi: 10.4088/pcc.v06n0403.
5
Bupropion extended-release for depressive disorders.
Expert Rev Neurother. 2008 May;8(5):715-22. doi: 10.1586/14737175.8.5.715.
6
Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.
CNS Drug Rev. 2006 Fall-Winter;12(3-4):178-207. doi: 10.1111/j.1527-3458.2006.00178.x.
7
Extended-release bupropion induced grand mal seizures.
J Am Osteopath Assoc. 2007 Oct;107(10):441-2.

本文引用的文献

1
Duloxetine for the treatment of overactive bladder syndrome in multiple sclerosis: a pilot study.
Clin Neuropharmacol. 2012 Sep-Oct;35(5):231-4. doi: 10.1097/WNF.0b013e3182613dce.
2
Imipramine for enuresis associated with risperidone.
J Clin Psychopharmacol. 2011 Dec;31(6):782-3. doi: 10.1097/JCP.0b013e318235c330.
3
Bupropion in the treatment of major depressive disorder in real-life practice.
Clin Drug Investig. 2011 Oct 19;31 Suppl 1:19-24. doi: 10.2165/1159617-S0-000000000-00000.
4
The efficacy and tolerability of bupropion in the treatment of major depressive disorder.
Clin Drug Investig. 2011 Oct 19;31 Suppl 1:5-17. doi: 10.2165/1159616-S0-000000000-00000.
6
Bupropion induced serotonin syndrome: a case report.
J Med Toxicol. 2010 Jun;6(2):168-71. doi: 10.1007/s13181-010-0021-x.
7
The efficacy of venlafaxine in the treatment of women with stress urinary incontinence.
Arch Gynecol Obstet. 2009 Mar;279(3):343-8. doi: 10.1007/s00404-008-0729-x. Epub 2008 Jul 16.
8
Bupropion: a review of its use in the management of major depressive disorder.
Drugs. 2008;68(5):653-89. doi: 10.2165/00003495-200868050-00011.
9
Review: Bupropion and SSRI-induced side effects.
J Psychopharmacol. 2008 Sep;22(7):792-804. doi: 10.1177/0269881107083798. Epub 2008 Feb 28.
10
Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.
CNS Drug Rev. 2006 Fall-Winter;12(3-4):178-207. doi: 10.1111/j.1527-3458.2006.00178.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验